This website uses cookies to enhance the user experience.
S

SCLEROMAX AS828 331 132

Research
Limited company
Fredriksborgveien 50A 0286 OSLO, Norge

SCLEROMAX AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
4 years
since Dec 14, 2021
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person

Financials

Annual total result 2023
-26,841
NOK
Total equity 2023
-31,912
NOK
Last update: Sep 16, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly

Others

NameRoleShares
E
ECIT RÅD & REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
30,000
100 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year20232022
Total operating income
0
0
Annual Total Result
-26,841
-29,500
Total assets
4,885
2,680
Total liabilities
36,797
7,750
Total equity
-31,912
-5,070

P&L

Year20232022
Total operating income
0
0
Total operating costs
26,842
29,494
Operating result
-26,842
-29,494
Financial income/costs
0
-6
Profit before tax
-26,841
-29,500
Total tax & extraordinary income/cost
0
0
Annual Total Result
-26,841
-29,500

Balance overview

Year20232022
Total fixed assets
0
0
Total current assets
4,885
2,680
Total assets
4,885
2,680
Short term debt
36,797
7,750
Long term debt
0
0
Total liabilities
36,797
7,750
Contributed capital
30,000
30,000
Retained earnings
-61,912
-35,070
Total equity
-31,912
-5,070
Total equity and liabilities
4,885
2,680

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology